#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Transplant rejection Oropharyngeal squamous cell carcinoma Intracranial calcification Primary amyloidosis Monogenic diabetes VEXAS syndrome Langerhans cell sarcoma B precursor type acute leukaemia Endometrial adenocarcinoma Antiphospholipid syndrome Hyperadrenocorticism Ovarian cancer stage IV Glycogen storage disease type V Necrotising myositis Gaucher's disease type III More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease Pleural mesothelioma malignant – Trials in Disease Skin angiosarcoma – Trials in Disease Osteosarcoma metastatic – Life with Disease Focal segmental glomerulosclerosis – Treatment Primary immunodeficiency syndrome – Diagnostics CADASIL – Trials in Disease Acute respiratory distress syndrome – Trials in Disease Marginal zone lymphoma refractory – Diagnostics Haemophilia A without inhibitors – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Eltrombopag Pentosan Polysulfate Sodium Clomifene Citrate Rifamycin Sodium Acetylcysteine Tumour Detection Thiamine Nitrate Bp S227928 Vindesine Sulfate Zongertinib Loperamide Hydrochloride Capmatinib Thiamine Nitrate AZD4512 Betahistine Dihydrochloride Neob Tamoxifen Daridorexant Losartan Potassium GUAIACOL More therapies…

    Learn about Your Condition

    Still's disease Endotracheal intubation Leiomyosarcoma metastatic HER2 positive gastric cancer Thyroid mass Anal incontinence Marginal zone lymphoma Herpes simplex meningitis Eczema Gingival bleeding Cirrhosis alcoholic Seizure Vesicoureteric reflux Head and neck cancer stage III Familial mediterranean fever More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ewing’s sarcoma

  • Long-term safety study of GD2IL18CART treatment in patients with neuroblastoma, osteosarcoma, Ewing sarcoma, or advanced breast cancer

    Recruiting

    1 1 1
    Investigated Drugs:
    • Gd2Il18Cart
    Germany

  • Study of Regorafenib and Maintenance Chemotherapy for Newly Diagnosed Ewing Sarcoma Patients with Metastatic Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Cyclophosphamide
    • Vinorelbine
    Denmark France The Netherlands Norway Spain

  • Study on Dinutuximab Beta and Drug Combination for Children, Teens, and Adults with GD2-Positive Ewing Sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Dinutuximab Beta
    • Mesna
    • Filgrastim
    Austria Czechia Germany Sweden

  • Study to Find the Right Dose and Safety of Lutetium (177Lu) Edotreotide and Arginine-Lysine in Children with Somatostatin Receptor-Positive Tumors

    Recruiting

    1 1 1
    Investigated Diseases:
    • Central nervous system neoplasm
    • Neuroendocrine tumour
    • Peripheral primitive neuroectodermal tumour of soft tissue
    Investigated Drugs:
    • Lutetium (177Lu) Edotreotide
    • L-Arginine Hydrochloride
    • L-Lysine Hydrochloride
    France Italy Spain

  • Study of drug combination therapy for patients with recurrent and primary refractory Ewing Sarcoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Ewing’s sarcoma recurrent
    • Extra-osseous Ewing’s sarcoma
    • Extra-osseous Ewing’s sarcoma metastatic
    Investigated Drugs:
    • Etoposide Phosphate
    • Anhydrous Docetaxel
    • Ifosfamide
    Austria Belgium Czechia Denmark Finland France +4

  • Study on the Effectiveness and Safety of Naxitamab for Patients with Refractory Ewing’s Sarcoma

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ewing’s sarcoma
    Investigated Drugs:
    • Naxitamab
    Poland
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!